Literature DB >> 11131535

Transplantation of human fetal striatal tissue in Huntington's disease: rationale for clinical studies.

T B Freeman1, R A Hauser, A E Willing, T Zigova, P R Sanberg, S Saporta.   

Abstract

Huntington's disease is a fatal neurological disorder characterized by chorea and deterioration in cognitive and neuropsychiatric function. Primary pathological changes are found in the striatum, where GABAergic neurons undergo degenerative changes. Local interneurons are relatively spared. Here, we describe the rationale for clinical trials of fetal striatal tissue transplantation for the treatment of Huntington's disease. Specifically, the reasons for utilizing tissue derived from the far lateral aspect of the lateral ventricular eminence as a source of striatal tissue will be discussed.

Entities:  

Mesh:

Year:  2000        PMID: 11131535     DOI: 10.1002/0470870834.ch8

Source DB:  PubMed          Journal:  Novartis Found Symp        ISSN: 1528-2511


  3 in total

1.  Human pluripotent stem cell therapy for Huntington's disease: technical, immunological, and safety challenges human pluripotent stem cell therapy for Huntington's disease: technical, immunological, and safety challenges.

Authors:  Camille Nicoleau; Pedro Viegas; Marc Peschanski; Anselme L Perrier
Journal:  Neurotherapeutics       Date:  2011-10       Impact factor: 7.620

2.  Neural transplants in patients with Huntington's disease undergo disease-like neuronal degeneration.

Authors:  F Cicchetti; S Saporta; R A Hauser; M Parent; M Saint-Pierre; P R Sanberg; X J Li; J R Parker; Y Chu; E J Mufson; J H Kordower; T B Freeman
Journal:  Proc Natl Acad Sci U S A       Date:  2009-07-20       Impact factor: 11.205

3.  Striatal progenitors derived from human ES cells mature into DARPP32 neurons in vitro and in quinolinic acid-lesioned rats.

Authors:  Laetitia Aubry; Aurore Bugi; Nathalie Lefort; France Rousseau; Marc Peschanski; Anselme L Perrier
Journal:  Proc Natl Acad Sci U S A       Date:  2008-10-15       Impact factor: 11.205

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.